報價延遲最少15分鐘:2025/01/21 08:53 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
-- 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.46/-0.57
|
|
企業價值
1.41B
|
| 資產負債 |
|
每股賬面淨值
1.54
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
200.52M
|
|
每股收益
0.58
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 08:53 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa. |